loadpatents
Patent applications and USPTO patent grants for UBI US Holdings LLC.The latest application filed is for "artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response".
Patent | Date |
---|---|
Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients Grant 11,292,839 - Wang April 5, 2 | 2022-04-05 |
Artificial Promiscuous T Helper Cell Epitopes That Facilitate Targeted Antibody Production With Limited T Cell Inflammatory Response App 20220023400 - WANG; Chang Yi | 2022-01-27 |
Antibodies directed against CD4 for the treatment and functional cure of HIV Grant 11,180,555 - Wang November 23, 2 | 2021-11-23 |
Peptide Immunogens Of Il-31 And Formulations Thereof For The Treatment And/or Prevention Of Atopic Dermatitis App 20210079054 - WANG; Chang Yi | 2021-03-18 |
Treatment And Sustained Virologic Remission Of Hiv Infection By Antibodies To Cd4 In Haart Stabilized Patients App 20190194326 - WANG; Chang Yi | 2019-06-27 |
Treatment And Functional Cure Of HIV Infection By Monoclonal Antibodies To CD4 Mediating Competitive HIV Entry Inhibition App 20170369576 - WANG; Chang Yi | 2017-12-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.